Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Lung Cancer

Free Subscription 23.04.2008 2 Ann Oncol 3 Ann Thorac Surg 1 Br J Cancer 2 Cancer 1 Cancer Chemother Pharmacol 1 Cancer Lett 5 Clin Cancer Res 1 Eur J Cancer 1 J Clin Invest 4 J Clin Oncol 5 J Thorac Oncol 4 Lung Cancer 2 Oncogene

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Oncol

1. PAPAXOINIS G , Fountzilas G, Rontogianni D, Dimopoulos MA, et al
   Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG).
   Ann Oncol. 2008;19:780-6.
   PubMed     Related articles    Abstract available
   
   
2. FULCINITI F , Losito S, Botti G, Di Mattia D, et al
   Metastases to the breast: role of fine needle cytology samples. Our experience with nine cases in 2 years.
   Ann Oncol. 2008;19:682-7.
   PubMed     Related articles    Abstract available
   
   

   
   Ann Thorac Surg

3. YAN H , Cheng C, Haouala A, Krueger T, et al
   Distribution of free and liposomal doxorubicin after isolated lung perfusion in a sarcoma model.
   Ann Thorac Surg. 2008;85:1225-32.
   PubMed     Related articles    Abstract available
   
   
4. KESLER KA , Hammoud ZT, Rieger KM, Kruter LE, et al
   Carinaplasty airway closure: a technique for right pneumonectomy.
   Ann Thorac Surg. 2008;85:1178-85.
   PubMed     Related articles    Abstract available
   
   
5. FERGUSON MK , Vigneswaran WT
   Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease.
   Ann Thorac Surg. 2008;85:1158-64.
   PubMed     Related articles    Abstract available
   
   

   
   Br J Cancer

6. XING J , Stewart DJ, Gu J, Lu C, et al
   Expression of methylation-related genes is associated with overall survival in patients with non-small cell lung cancer.
   Br J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   

   
   Cancer

7. VAN DER KNAAP R , Siemes C, Coebergh JW, van Duijn CM, et al
   Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study.
   Cancer. 2008;112:748-57.
   PubMed     Related articles    Abstract available
   
   
8. SENECAL D , Jais JP, Desablens B, Berthou C, et al
   Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
   Cancer. 2007;.
   PubMed     Related articles    Abstract available
   
   

   
   Cancer Chemother Pharmacol

9. YAMAMOTO N , Horiike A, Fujisaka Y, Murakami H, et al
   Phase I dose-finding and pharmacokinetic study of the oral epidermal growth factor receptor tyrosine kinase inhibitor Ro50-8231 (erlotinib) in Japanese patients with solid tumors.
   Cancer Chemother Pharmacol. 2008;61:489-96.
   PubMed     Related articles    Abstract available
   
   

   
   Cancer Lett

10. ZHU JQ , Zhong WZ, Zhang GC, Li R, et al
    Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signals.
    Cancer Lett. 2008;.
    PubMed     Related articles    Abstract available
    
    

    
    Clin Cancer Res

11. BACH P
    Computed tomography screening for lung cancer.
    Clin Cancer Res. 2008;14:2511.
    PubMed     Related articles   
    
    
12. SILVESTRI GA
    Deaths among Patients with Screen-Detected Lung Cancer.
    Clin Cancer Res. 2008;14:2511.
    PubMed     Related articles   
    
    
13. KATO T , Sato N, Takano A, Miyamoto M, et al
    Activation of Placenta-Specific Transcription Factor Distal-less Homeobox 5 Predicts Clinical Outcome in Primary Lung Cancer Patients.
    Clin Cancer Res. 2008;14:2363-70.
    PubMed     Related articles    Abstract available
    
    
14. KIM JH , Bogner PN, Baek SH, Ramnath N, et al
    Up-regulation of peroxiredoxin 1 in lung cancer and its implication as a prognostic and therapeutic target.
    Clin Cancer Res. 2008;14:2326-33.
    PubMed     Related articles    Abstract available
    
    
15. KAMALIAN L , Gosney JR, Forootan SS, Foster CS, et al
    Increased expression of id family proteins in small cell lung cancer and its prognostic significance.
    Clin Cancer Res. 2008;14:2318-25.
    PubMed     Related articles    Abstract available
    
    

    
    Eur J Cancer

16. BUENO L , de Alwis DP, Pitou C, Yingling J, et al
    Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-beta kinase antagonist, in mice.
    Eur J Cancer. 2008;44:142-50.
    PubMed     Related articles    Abstract available
    
    

    
    J Clin Invest

17. AIKAWA T , Whipple CA, Lopez ME, Gunn J, et al
    Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells.
    J Clin Invest. 2008;118:89-99.
    PubMed     Related articles    Abstract available   Free Full Text
    
    

    
    J Clin Oncol

18. COSTA DB , Schumer ST, Tenen DG, Kobayashi S, et al
    Differential responses to erlotinib in epidermal growth factor receptor (EGFR)-mutated lung cancers with acquired resistance to gefitinib carrying the L747S or T790M secondary mutations.
    J Clin Oncol. 2008;26:1182-4.
    PubMed     Related articles   
    
    
19. ANKER CJ , Dechet C, Isaac JC, Akerley W, et al
    Small-cell carcinoma of the prostate.
    J Clin Oncol. 2008;26:1168-71.
    PubMed     Related articles   
    
    
20. RUDIN CM , Liu W, Desai A, Karrison T, et al
    Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity.
    J Clin Oncol. 2008;26:1119-27.
    PubMed     Related articles    Abstract available
    
    
21. BROUWERS MC , Somerfield MR, Browman GP
    A for effort: learning from the application of the GRADE approach to cancer guideline development.
    J Clin Oncol. 2008;26:1025-6.
    PubMed     Related articles   
    
    

    
    J Thorac Oncol

22. HOWE KL , Leighl NB
    Factors contributing to adjuvant therapy decisions.
    J Thorac Oncol. 2008;3:195-6.
    PubMed     Related articles   
    
    
23. SOS ML , Zander T, Thomas RK, Staratschek-Jox A, et al
    Expression of signaling mediators downstream of EGF-receptor predict sensitivity to small molecule inhibitors directed against the EGF-receptor pathway.
    J Thorac Oncol. 2008;3:170-3.
    PubMed     Related articles    Abstract available
    
    
24. MARKS JL , Broderick S, Zhou Q, Chitale D, et al
    Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma.
    J Thorac Oncol. 2008;3:111-6.
    PubMed     Related articles    Abstract available
    
    
25. KRYSAN K , Lee JM, Dohadwala M, Gardner BK, et al
    Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistance.
    J Thorac Oncol. 2008;3:107-10.
    PubMed     Related articles    Abstract available
    
    
26. MOK TS , Crowley J
    Big question, small answer.
    J Thorac Oncol. 2008;3:105-6.
    PubMed     Related articles   
    
    

    
    Lung Cancer

27. LI M , Yin Z, Guan P, Li X, et al
    XRCC1 polymorphisms, cooking oil fume and lung cancer in Chinese women nonsmokers.
    Lung Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
28. MYUNG JK , Choe G, Chung DH, Seo JW, et al
    A simple inflation method for frozen section diagnosis of minute precancerous lesions of the lung.
    Lung Cancer. 2008;59:198-202.
    PubMed     Related articles    Abstract available
    
    
29. LI YY , Chang JW, Chou WC, Liaw CC, et al
    Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Lung Cancer. 2008;59:180-91.
    PubMed     Related articles    Abstract available
    
    
30. SAGAWA M , Aikawa H, Usuda K, Machida Y, et al
    Extended sleeve pulmonary resection in a patient with synchronous triple bronchogenic squamous cell carcinoma.
    Lung Cancer. 2008;59:262-5.
    PubMed     Related articles    Abstract available
    
    

    
    Oncogene

31. LI D , Ambrogio L, Shimamura T, Kubo S, et al
    BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models.
    Oncogene. 2008;.
    PubMed     Related articles    Abstract available
    
    
32. OGIWARA H , Kohno T, Nakanishi H, Nagayama K, et al
    Unbalanced translocation, a major chromosome alteration causing loss of heterozygosity in human lung cancer.
    Oncogene. 2008;.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: